United StatesNiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 tablets per bottle (NDC 62175-322-46) distributed by Lannett Company, Philadelphia, PA are recalled — affected lots include 21264027A (Exp 10/30/2025); 22266446A (Exp 12/31/2025); 22266901A (Exp 02/28/2026); 22267553A, 22267554A (Exp 03/31/2026); 22267555A (Exp 02/28/2026); 22267992A (Exp 04/30/2026); 22267993A, 22267994A (Exp 05/31/2026). The recall is due to failed dissolution specifications and is ongoing, covering 46,848 90-count bottles distributed nationwide in the USA.
What's being recalled
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46
Recalling firm: Lannett Company Inc., Seymour, IN, United States.
How to identify it
Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026
The hazard
Failed Dissolution Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)